| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | — | — |
| Cost of Revenue | $789K | — | — |
| Gross Profit | $3.2M | — | — |
| R&D Expense | $1.0M | — | -19.5% |
| SG&A Expense | $2.9M | — | -13.9% |
| Operating Income | -$5.3M | — | +17.9% |
| Pre-tax Income | -$5.3M | — | +17.6% |
| Income Tax | $264K | — | +0.0% |
| Net Income | -$5.5M | — | +16.9% |
| EPS (Basic) | -$0.06 | — | +33.3% |
| EPS (Diluted) | -$0.06 | — | +33.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | +85.9% | — |
| Accounts Receivable | $4.0M | — | — |
| Inventory | $22.6M | +1.6% | +57.4% |
| Current Assets | $37.1M | +34.9% | +117.5% |
| Total Assets | $110.0M | +8.9% | +21.5% |
| Current Liabilities | $44.7M | -9.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.4M | — | — |
| Investing Cash Flow | -$4.4M | — | — |
| Financing Cash Flow | $15.1M | — | — |
| +3.0% |
| Total Liabilities | $51.6M | -8.1% | +4.8% |
| Stockholders' Equity | $58.4M | +30.2% | +41.5% |